Literature DB >> 19342645

Inositol 1,4,5-trisphosphate 3-kinase B is a negative regulator of BCR signaling that controls B cell selection and tolerance induction.

Andrew T Miller1, Daniel R Beisner, Daorong Liu, Michael P Cooke.   

Abstract

Inositol 1,4,5-trisphosphate 3-kinase B (or Itpkb) converts inositol 1,4,5-trisphosphate to inositol 1,3,4,5-tetrakisphosphate upon Ag receptor activation and controls the fate and function of lymphocytes. To determine the role of Itpkb in B cell tolerance, Itpkb(-/-) mice were crossed to transgenic mice that express a BCR specific for hen egg lysozyme (IgHEL). B cells from Itpkb(-/-) IgHEL mice possess an anergic phenotype, hypoproliferate in response to cognate Ag, and yet they exhibit enhanced Ag-induced calcium signaling. In IgHEL transgenic mice that also express soluble HEL, lack of Itpkb converts anergy induction to deletion. These data establish Itpkb as a negative regulator of BCR signaling that controls the fate of developing B cells and tolerance induction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19342645     DOI: 10.4049/jimmunol.0802850

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

Review 1.  Defining signal transduction by inositol phosphates.

Authors:  Stephen B Shears; Sindura B Ganapathi; Nikhil A Gokhale; Tobias M H Schenk; Huanchen Wang; Jeremy D Weaver; Angelika Zaremba; Yixing Zhou
Journal:  Subcell Biochem       Date:  2012

Review 2.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 3.  Calcium Signaling: From Normal B Cell Development to Tolerance Breakdown and Autoimmunity.

Authors:  Patrice Hemon; Yves Renaudineau; Marjolaine Debant; Nelig Le Goux; Sreya Mukherjee; Wesley Brooks; Olivier Mignen
Journal:  Clin Rev Allergy Immunol       Date:  2017-10       Impact factor: 8.667

4.  Inhibition of inositol kinase B controls acute and chronic graft-versus-host disease.

Authors:  Govindarajan Thangavelu; Jing Du; Katelyn G Paz; Michael Loschi; Michael C Zaiken; Ryan Flynn; Patricia A Taylor; Andrew Kemal Kirchmeier; Angela Panoskaltsis-Mortari; Leo Luznik; Kelli P MacDonald; Geoffrey R Hill; Ivan Maillard; David H Munn; Jonathan S Serody; William J Murphy; David Miklos; Corey S Cutler; John Koreth; Joseph H Antin; Robert J Soiffer; Jerome Ritz; Carol Dahlberg; Andrew T Miller; Bruce R Blazar
Journal:  Blood       Date:  2020-01-02       Impact factor: 22.113

5.  Tonic BCR signaling represses receptor editing via Raf- and calcium-dependent signaling pathways.

Authors:  Laura B Ramsey; Amanda L Vegoe; Andrew T Miller; Michael P Cooke; Michael A Farrar
Journal:  Immunol Lett       Date:  2010-10-07       Impact factor: 3.685

Review 6.  Lipid signaling in T-cell development and function.

Authors:  Yina H Huang; Karsten Sauer
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-10-13       Impact factor: 10.005

Review 7.  Inositol trisphosphate 3-kinases: focus on immune and neuronal signaling.

Authors:  Michael J Schell
Journal:  Cell Mol Life Sci       Date:  2010-01-12       Impact factor: 9.261

8.  Inositol 1,4,5-trisphosphate 3-kinase B promotes Ca2+ mobilization and the inflammatory activity of dendritic cells.

Authors:  Laura Marongiu; Francesca Mingozzi; Clara Cigni; Roberta Marzi; Marco Di Gioia; Massimiliano Garrè; Dario Parazzoli; Laura Sironi; Maddalena Collini; Reiko Sakaguchi; Takashi Morii; Mariacristina Crosti; Monica Moro; Stéphane Schurmans; Tiziano Catelani; Rany Rotem; Miriam Colombo; Stephen Shears; Davide Prosperi; Ivan Zanoni; Francesca Granucci
Journal:  Sci Signal       Date:  2021-03-30       Impact factor: 8.192

9.  IP3 3-kinase opposes NGF driven neurite outgrowth.

Authors:  Richard Eva; Dalila Bouyoucef-Cherchalli; Kalpana Patel; Peter J Cullen; George Banting
Journal:  PLoS One       Date:  2012-02-22       Impact factor: 3.240

Review 10.  Lipid and Protein Co-Regulation of PI3K Effectors Akt and Itk in Lymphocytes.

Authors:  Xinxin Wang; Leonard Benjamin Hills; Yina Hsing Huang
Journal:  Front Immunol       Date:  2015-03-13       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.